105 related articles for article (PubMed ID: 25299638)
1. Sugammadex: A Comprehensive Review of the Published Human Science, Including Renal Studies.
Partownavid P; Romito BT; Ching W; Berry AA; Barkulis CT; Nguyen KP; Jahr JS
Am J Ther; 2015; 22(4):298-317. PubMed ID: 25299638
[TBL] [Abstract][Full Text] [Related]
2. Sugammadex: A Scientific Review Including Safety and Efficacy, Update on Regulatory Issues, and Clinical Use in Europe.
Jahr JS; Miller JE; Hiruma J; Emaus K; You M; Meistelman C
Am J Ther; 2015; 22(4):288-97. PubMed ID: 25299637
[TBL] [Abstract][Full Text] [Related]
3. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular transmission: new concepts and agents.
de Boer HD
J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
6. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
Ren WH; Jahr JS
Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
[TBL] [Abstract][Full Text] [Related]
7. A persistent 'can't intubate, can't oxygenate' crisis despite rocuronium reversal with sugammadex.
Kyle BC; Gaylard D; Riley RH
Anaesth Intensive Care; 2012 Mar; 40(2):344-6. PubMed ID: 22417032
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex: another milestone in clinical neuromuscular pharmacology.
Naguib M
Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
[TBL] [Abstract][Full Text] [Related]
9. Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion.
Haerter F; Eikermann M
Expert Opin Pharmacother; 2016; 17(6):819-33. PubMed ID: 26799963
[TBL] [Abstract][Full Text] [Related]
10. Sugammadex: the first selective binding reversal agent for neuromuscular block.
Kovac AL
J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
[TBL] [Abstract][Full Text] [Related]
11. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
Hogg RM; Mirakhur RK
Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
[TBL] [Abstract][Full Text] [Related]
12. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
13. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
14. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.
Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B
Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435
[TBL] [Abstract][Full Text] [Related]
15. Sugammadex: a selective relaxant-binding agent providing rapid reversal.
Rex C; Bergner UA; Pühringer FK
Curr Opin Anaesthesiol; 2010 Aug; 23(4):461-5. PubMed ID: 20489603
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone produces dose-dependent inhibition of sugammadex reversal in in vitro innervated primary human muscle cells.
Rezonja K; Sostaric M; Vidmar G; Mars T
Anesth Analg; 2014 Apr; 118(4):755-63. PubMed ID: 24651229
[TBL] [Abstract][Full Text] [Related]
17. Rapid reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients with liver dysfunction undergoing hepatic surgery.
Fujita A; Ishibe N; Yoshihara T; Ohashi J; Makino H; Ikeda M; Setoguchi H
Acta Anaesthesiol Taiwan; 2014 Jun; 52(2):54-8. PubMed ID: 25016508
[TBL] [Abstract][Full Text] [Related]
18. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
19. New drug sugammadex: a selective relaxant binding agent.
Welliver M
AANA J; 2006 Oct; 74(5):357-63. PubMed ID: 17048555
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of sugammadex.
Caldwell JE; Miller RD
Anaesthesia; 2009 Mar; 64 Suppl 1():66-72. PubMed ID: 19222433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
